logo
logo

Integrated Dna Technologies Acquires Archerdx Next Generation Sequencing Research Assays From Invitae Corporation

Integrated Dna Technologies Acquires Archerdx Next Generation Sequencing Research Assays From Invitae Corporation

12/20/22, 12:33 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgboulder
Integrated DNA Technologies, Inc. (IDT) today announced it closed on the purchase of Next Generation Sequencing (NGS) research assays from Invitae Corporation (NYSE: NVTA) under the trademarked name Archer®. The integration of IDT’s portfolio with the acquired NGS research assays—which have been foundational in researching novel cancer fusions—will empower labs with an all-in-one solution to uncover biomarkers and advance cancer discoveries. The transaction enables IDT to expand its existing operations, build upon the legacy Archer portfolio, and welcome more than 100 new associates globally.

Company Info

Company
Integrated DNA Technologies
Company info
Integrated DNA Technologies, Inc. (IDT) is a genomics solutions provider that empowers genomics laboratories with advanced oligonucleotide manufacturing processes. With over 35 years of experience, IDT supports key application areas such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference.